News

Intermap Technologies Reports Solid Growth in Insurance Sector

Intermap Technologies Reports Solid Growth in Insurance Sector

Intermap Technologies Reports Solid Growth in Insurance Sector

Intermap Technologies, known for its advancements in 3D geospatial intelligence solutions, has kicked off 2025 with remarkable success in its insurance segment, achieving awards exceeding $1.1 million. This notable accomplishment is attributed to new client subscriptions and key renewal contracts.

Strategic Partnerships Drive Growth

The onset of the year has brought significant opportunities for Intermap as the company secures two new strategic partnerships with major insurance clients. These collaborative efforts exemplify Intermap's commitment to enhancing risk assessment and offering cutting-edge solutions to the insurance industry.

Innovative Solutions for Natural Hazards

One of the standout collaborations is with a large, multiyear subscription agreement made with a prominent bank-insurance conglomerate operating across multiple European countries. This partnership highlights the adoption of Intermap's state-of-the-art Aquarius RMA solution, specifically designed to assess risks related to natural hazards and climate change impacts. With the use of artificial intelligence and continuously updated 3D terrain data, Intermap delivers precise risk assessments that guide insurance processes from underwriting through to claims management. This empowers insurance firms to implement innovative, data-driven strategies to address climate and sustainability challenges effectively.

Enhancing Underwriting Precision

Another significant partnership has emerged with PREMIUM Insurance Company Limited, which has integrated Intermap's advanced natural hazard solutions into its operations. This collaboration is vital for improving flood risk management, allowing homeowners and businesses to make informed decisions regarding their insurance coverage.

Marek Benko, a member of PREMIUM Insurance’s Board of Directors, emphasized the importance of high-quality flood maps and robust risk assessments for property insurance in the Czech Republic and Slovakia, stating that leveraging Intermap’s advanced mapping tools enhances their underwriting accuracy and trust with reinsurers.

Growing Demand for Geospatial Solutions

Patrick A. Blott, Intermap's Chairman and CEO, noted a notable increase in demand for their geospatial applications, which has driven record revenue early in the year. The uniqueness of Intermap's data products fosters a loyal subscriber base with minimal churn. He added, "Insurance companies are increasingly utilizing 3D geospatial data to improve their risk assessments and unveil property vulnerabilities to risks like floods or wildfires. Our NEXTMap solution embodies the integration of artificial intelligence and machine learning, enabling the creation of globally accessible digital elevation models with exceptional precision, ultimately facilitating data-driven decision-making for our clients across various sectors."

Upcoming Financial Results Announcement

As the company continues to build on its momentum, it is poised to announce its fourth quarter and full year results, with a live conference call scheduled for March 27, 2025. During this event, executives will share insights on the company’s performance and updates, providing an open forum for investor questions.

Conference Call Details

Date and Time

The live webinar is set for March 27, 2025, at 5:00 PM ET.

How to Participate

Investors and stakeholders can register to participate in this important call, where Intermap will elaborate on its successes and strategies moving forward.

About Intermap Technologies

Established in 1997 and headquartered in Denver, Colorado, Intermap Technologies (TSX: IMP; OTCQB: ITMSF) has emerged as a trailblazer in geospatial intelligence. The company focuses on rigorous scientific analysis and the production of high-resolution 3D terrain data, ensuring a seamless integration of such intelligence into various workflows for its diverse clientele. Intermap’s innovative capabilities in artificial intelligence and machine learning are redefining how governments and businesses understand and utilize geospatial data for critical applications ranging from disaster mitigation to environmental planning.

Frequently Asked Questions

What recent achievements has Intermap Technologies made in 2025?

Intermap has surpassed $1.1 million in awards within its insurance sector due to new client subscriptions and renewals.

How does Intermap support its insurance partners?

Intermap provides innovative geospatial solutions, including the Aquarius RMA solution, for effective risk quantification related to natural hazards and climate change.

What is the significance of the partnership with PREMIUM Insurance?

This partnership allows for enhanced flood risk management in Europe, helping clients make informed decisions based on improved mapping and risk assessment tools.

When will Intermap release its financial results for 2024?

Intermap will announce its fourth quarter and full year 2024 results on March 27, 2025.

How does Intermap's technology improve risk assessments?

By using advanced 3D geospatial data and incorporating artificial intelligence, Intermap enhances the precision of risk assessments related to property vulnerabilities such as floods or wildfires.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 250

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 353

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading